CAPRICOR THERAPEUTICS, INC. Logo

CAPRICOR THERAPEUTICS, INC.

A clinical-stage biotech developing cell and exosome-based biologics for serious diseases.

CAPR | US

Overview

Corporate Details

ISIN(s):
US14070B3096
LEI:
Country:
United States of America
Address:
10865 ROAD TO THE CURE, 92121 SAN DIEGO

Description

Capricor Therapeutics is a clinical-stage biotechnology company focused on the development of biologics, primarily cell and exosome-based technologies. The company's science is centered on its proprietary platform of allogeneic cardiosphere-derived cells (CDCs) and engineered exosomes to create novel therapeutics. Its lead candidate, Deramiocel (CAP-1002), is a cell therapy that has completed a pivotal Phase 3 study for the treatment of Duchenne muscular dystrophy (DMD). Capricor's pipeline leverages its core technologies to treat or prevent a broad range of serious diseases with significant unmet medical needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-23 15:55 English ZIP 7.6 KB
2025-12-05 23:29
424B5
English ZIP 194.2 KB
2025-12-05 23:07
8-K
English ZIP 263.0 KB
2025-12-05 12:01
424B3
English ZIP 19.7 KB
2025-12-04 22:30
424B5
English ZIP 165.1 KB
2025-12-03 15:29
8-K
English ZIP 2.5 MB
2025-12-03 13:21
8-K
English ZIP 102.0 KB
2025-11-10 23:20
10-Q
English ZIP 1.5 MB
2025-11-10 22:01
8-K
English ZIP 110.2 KB
2025-10-30 19:57 English ZIP 8.3 KB
2025-09-24 06:15 English ZIP 5.2 KB
2025-09-10 23:26
S-3
English ZIP 341.6 KB
2025-08-11 23:25
10-Q
English ZIP 1.4 MB
2025-08-11 22:06
8-K
English ZIP 112.1 KB
2025-07-29 17:23 English ZIP 8.3 KB

Automate Your Workflow. Get a real-time feed of all CAPRICOR THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CAPRICOR THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CAPRICOR THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.